Publications by authors named "Leonard Glass"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

8,066

Total Likes

903

Extended Reach

3,576,109

Social Features

227
I
Incretin-based investigational therapies for the treatment of MASLD/MASH.
Bram Brouwers, Girish Rao, Yuanyuan Tang, Ángel Rodríguez, Leonard C Glass

Diabetes Res Clin Pract· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of a patient self-directed mealtime insulin titration algorithm: a US payer perspective.
Bradley H Curtis, Sarah Curtis, Daniel R Murphy, James C Gahn, Sinem Perk, Leonard C Glass

J Med Econ· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Patient-Driven Approach to Manage Mealtime Insulin Titration: Tools From the AUTONOMY Study.
Allison Camacho, Jennal Johnson, Jeffrey S Bonner, Leonard C Glass

Diabetes Educ· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Where the rubber meets the road: the challenge of reporting colleagues' boundary violations.
Leonard L Glass

AMA J Ethics· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin Lispro with Continuous Subcutaneous Insulin Infusion is Safe and Effective in Patients with Type 2 Diabetes: A Randomized Crossover Trial of Insulin Lispro Versus Insulin Aspart.
James Thrasher, Anuj Bhargava, Tina M Rees, Tao Wang, Cristina B Guzman, Leonard C Glass

Endocr Pract· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to comment on Edelman et al. AUTONOMY: the first randomized trial comparing two patient-driven approaches to initiate and titrate prandial insulin lispro in type 2 diabetes. Diabetes Care 2014;37:2132-2140.
Steve V Edelman, Rong Liu, Jennal Johnson, Leonard C Glass

Diabetes Care· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AUTONOMY: the first randomized trial comparing two patient-driven approaches to initiate and titrate prandial insulin lispro in type 2 diabetes.
Steve V Edelman, Rong Liu, Jennal Johnson, Leonard C Glass

Diabetes Care· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes.
Gregory Gaich, Jenny Y Chien, Haoda Fu, Leonard C Glass, Mark A Deeg

Cell Metab· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline factors associated with glycemic control and weight loss when exenatide twice daily is added to optimized insulin glargine in patients with type 2 diabetes.
Julio Rosenstock, Sylvia K Shenouda, Richard M Bergenstal, John B Buse, Leonard C Glass

Diabetes Care· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
14-day in vitro chemical stability of insulin lispro in the MiniMed Paradigm pump.
Scott D Sharrow, Leonard C Glass, Michael A Dobbins

Diabetes Technol Ther· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of twice-daily exenatide in Basal insulin-treated patients with type 2 diabetes: a randomized, controlled trial.
John B Buse, Richard M Bergenstal, Leonard C Glass, Cory R Heilmann, Michelle S Lewis

Ann Intern Med· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pioglitazone improvement of fasting and postprandial hyperglycaemia in Mexican-American patients with Type 2 diabetes: a double tracer OGTT study.
Leonard C Glass, Kenneth Cusi, Rachele Berria, Roberta Petz, Eugenio Cersosimo

Clin Endocrinol (Oxf)· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of exenatide plus rosiglitazone on beta-cell function and insulin sensitivity in subjects with type 2 diabetes on metformin.
Ralph A DeFronzo, Curtis Triplitt, Yongming Qu, Michelle S Lewis, David Maggs, Leonard C Glass

Diabetes Care· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of exenatide combined with lifestyle modification in patients with type 2 diabetes.
Caroline M Apovian, Richard M Bergenstal, Robert M Cuddihy, Yongming Qu, Sheila Lenox, Leonard C Glass

Am J Med· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of exenatide versus insulin analogues on weight change in subjects with type 2 diabetes: a pooled post-hoc analysis.
Leonard C Glass, Yongming Qu, Sheila Lenox, Dennis Kim, Jeffrey R Gates

Curr Med Res Opin· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Model-based assessment of insulin sensitivity of glucose disposal and endogenous glucose production from double-tracer oral glucose tolerance test.
Karl Thomaseth, Alessandra Pavan, Rachele Berria, Leonard Glass, Ralph DeFronzo

Comput Methods Programs Biomed· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of glargine insulin versus rosiglitazone addition in poorly controlled type 2 diabetic patients on metformin plus sulfonylurea.
Curtis Triplitt, Leonard Glass, Yoshiniro Miyazaki, Estela Wajcberg, Amalia Gastaldelli

Diabetes Care· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The gray areas of boundary crossings and violations.
Leonard L Glass

Am J Psychother· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mohs out of control.
Leonard W Glass

Plast Reconstr Surg· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients.
Mandeep Bajaj, Swangjit Suraamornkul, Paul Piper, Lou J Hardies, Leonard Glass

J Clin Endocrinol Metab· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Images in clinical medicine. Pituitary apoplexy.
Leonard C Glass

N Engl J Med· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of birth weight discordance and prematurity on twin neonatal outcome.
Rachana Singh, Shital Doshi, Vesna G Sutija, Bianca Shah, Sunita Sidhu, Leonard Glass

J Perinat Med· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of ethnicity and familial diabetes on glucose tolerance and insulin action: a physiological analysis.
Ele Ferrannini, Amalia Gastaldelli, Masafumi Matsuda, Yoshinori Miyazaki, Maura Pettiti, Leonard Glass

J Clin Endocrinol Metab· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes.
Mandeep Bajaj, Swangjit Suraamornkul, Thongchai Pratipanawatr, Lou J Hardies, Wilailak Pratipanawatr, Leonard Glass

Diabetes· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis